Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients

NCT00127920 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Neoplasms

Interventions

DRUG: Avastin

Sponsor

Gynecologic Oncology Associates

Collaborators

[object Object]